Natera, Inc S-3ASR, filed Nov 15, 2022
Natera, Inc. (NTRA)
SECURITIES AND EXCHANGE COMMISSION
UNDER
THE SECURITIES ACT OF 1933
| |
Delaware
(State or other jurisdiction of
incorporation or organization) |
| |
01-0894487
(I.R.S. Employer
Identification Number) |
|
13011 McCallen Pass
Building A Suite 100
Austin, Texas 78753
(650) 249-9090
Chief Financial Officer
Natera, Inc.
13011 McCallen Pass
Building A Suite 100
Austin, Texas 78753
(650) 249-9090
| |
Jeffrey R. Vetter, Esq.
Jeffrey Thacker, Esq. John F. Dietz, Esq. Ryan J. Gunderson, Esq. Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP 550 Allerton Street Redwood City, California 94063 (650) 321-2400 |
| |
Daniel Rabinowitz, Esq.
Secretary and Chief Legal Officer Natera, Inc. 13011 McCallen Pass Building A Suite 100 Austin, Texas 78753 (650) 249-9090 |
| |
Alan F. Denenberg
Davis Polk & Wardwell LLP 1600 El Camino Real Menlo Park, California 94025 (650) 752-2000 |
|
From time to time after this Registration Statement becomes effective.
| | Large accelerated filer ☒ | | | Accelerated filer ☐ | | | Non-accelerated filer ☐ | | | Smaller reporting company ☐ | |
| | | | | | | | | | | Emerging growth company ☐ | |
| | | |
Page
|
| |||
| | | | | ii | | | |
| | | | | iv | | | |
| | | | | v | | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 4 | | | |
| | | | | 6 | | | |
| | | | | 9 | | | |
| | | | | 9 | | | |
| | | | | 10 | | | |
| | | | | 12 | | | |
| | | | | 15 | | | |
| | | | | 24 | | | |
| | | | | 24 | | | |
offering
| | | |
Nine months ended
September 30, (unaudited) |
| |
Year ended December 31,
|
| ||||||||||||||||||||||||
|
(in thousands, except per share data)
|
| |
2022
|
| |
2021
|
| |
2021
|
| |
2020
|
| |
2019
|
| |||||||||||||||
|
Selected Consolidated Statement of Operations Data:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Total revenues
|
| | | $ | 602,970 | | | | | $ | 452,458 | | | | | $ | 625,486 | | | | | $ | 391,005 | | | | | $ | 302,328 | | |
|
Total cost and expenses
|
| | | | 1,002,237 | | | | | | 780,966 | | | | | | 1,093,660 | | | | | | 607,282 | | | | | | 418,615 | | |
|
Interest expense and other income (expense), net
|
| | | | (5,402) | | | | | | (1,996) | | | | | | (2,924) | | | | | | (7,520) | | | | | | (6,541) | | |
|
Income tax expense
|
| | | | (557) | | | | | | (648) | | | | | | (618) | | | | | | (98) | | | | | | (1,999) | | |
|
Net loss
|
| | | $ | (405,226) | | | | | $ | (331,152) | | | | | $ | (471,716) | | | | | $ | (229,743) | | | | | $ | (124,827) | | |
|
Net loss per share, basic and diluted
|
| | | $ | (4.20) | | | | | $ | (3.72) | | | | | $ | (5.21) | | | | | $ | (2.84) | | | | | $ | (1.79) | | |
| | | |
As of
September 30, 2022 (unaudited) |
| |
As of December 31,
|
| ||||||||||||
| | | |
2021
|
| |
2020
|
| ||||||||||||
| Selected Consolidated Balance Sheet Data: | | | | | | | | | | | | | | | | | | | |
|
Cash and cash equivalents
|
| | | $ | 57,042 | | | | | $ | 84,614 | | | | | $ | 48,855 | | |
|
Restricted cash
|
| | | | 86 | | | | | | | | | | | | | | |
|
Short-term investments
|
| | | | 464,112 | | | | | | 829,896 | | | | | | 688,606 | | |
|
Inventory
|
| | | | 40,428 | | | | | | 26,909 | | | | | | 20,031 | | |
|
Property and equipment, net
|
| | | | 87,486 | | | | | | 65,516 | | | | | | 33,348 | | |
|
Total assets
|
| | | | 1,009,112 | | | | | | 1,236,487 | | | | | | 932,153 | | |
|
Debt
|
| | | | 331,483 | | | | | | 330,446 | | | | | | 252,547 | | |
|
Total liabilities
|
| | | | 647,491 | | | | | | 583,183 | | | | | | 445,917 | | |
|
Total stockholders’ equity
|
| | | | 361,621 | | | | | | 653,304 | | | | | | 486,236 | | |
| | | |
As of September 30, 2022
|
| |||||||||
| | | |
Actual(1)
|
| |
As Adjusted(1)
|
| ||||||
| | | |
(in thousands)
(unaudited) |
| |||||||||
|
Cash and cash equivalents
|
| | | $ | 57,042 | | | | | $ | 386,485 | | |
|
Restricted cash
|
| | | | 86 | | | | | | 86 | | |
|
Short-term investments
|
| | | | 464,112 | | | | | | 464,112 | | |
|
Short-term debt financing
|
| | | | 50,147 | | | | | | 50,147 | | |
|
Long-term debt financing
|
| | | | 281,336 | | | | | | 281,336 | | |
| Stockholders’ equity | | | | | | | | | | | | | |
|
Preferred stock, par value $0.0001 per share: 50,000 shares authorized, no shares issued and outstanding, actual and as adjusted
|
| | | | | | | | | | | | |
|
Common stock, par value $0.0001 per share: 750,000 shares authorized, 97,300 shares issued and outstanding, actual and 750,000 shares authorized, 107,170 shares issued and outstanding, as adjusted(1)
|
| | | | 10 | | | | | | 11 | | |
|
Additional paid-in capital
|
| | | | 2,181,282 | | | | | | 2,510,724 | | |
|
Accumulated deficit
|
| | | | (1,800,062) | | | | | | (1,800,062) | | |
|
Accumulated other comprehensive loss
|
| | | | (19,609) | | | | | | (19,609) | | |
|
Total stockholders’ equity
|
| | | | 361,621 | | | | | | 691,064 | | |
|
Total capitalization
|
| | | $ | 693,104 | | | | | $ | 1,022,547 | | |
|
Name
|
| |
Number of
Shares |
| |||
|
Morgan Stanley & Co. LLC
|
| | | | | | |
|
Cowen and Company, LLC
|
| | | | | | |
|
SVB Securities LLC
|
| |
|
| |||
|
Robert W. Baird & Co. Incorporated
|
| | | | | | |
|
Total
|
| | | | | | |
| | | | | | | | | |
Total
|
| |||||||||
| | | |
Per
Share |
| |
No
Exercise |
| |
Full
Exercise |
| |||||||||
|
Public offering price
|
| | | $ | | | | | $ | | | | | $ | | | |||
|
Underwriting discounts and commissions
|
| | | | | | | | | | | | | | | | | | |
|
Proceeds, before expenses, to us
|
| | | $ | | | | | $ | | | | | $ | | | | ||
| | Morgan Stanley | | |
Cowen
|
| |
SVB Securities
|
|
| | | | |
Baird
|
| | | |
INFORMATION NOT REQUIRED IN PROSPECTUS
| |
Registration fee – Securities and Exchange Commission
|
| | | $ | (1) | | |
| |
Printing and engraving expenses
|
| | | $ | 18,000 | | |
| |
Legal fees and expenses
|
| | | $ | 220,000 | | |
| |
Accounting fees and expenses
|
| | | $ | 120,000 | | |
| |
Transfer agent fees and expenses
|
| | | $ | 5,000 | | |
| |
Miscellaneous
|
| | | $ | 25,000 | | |
| |
Total
|
| | | | | | |
| | | | | | |
Incorporated by reference herein
|
| | | | |||||||||
|
Exhibit No.
|
| |
Description
|
| |
Form
|
| |
File No.
|
| |
Exhibit
|
| |
Filing Date
|
| |
Filed Herewith
|
|
| 1.1* | | | Form of Underwriting Agreement | | | | | | | | | | | | | | | | |
| 3.1 | | | | |
8-K
|
| |
001-37478
|
| |
3.1
|
| |
07/09/2015
|
| | | | |
| 3.2 | | | | |
10-Q
|
| |
001-37478
|
| |
3.1
|
| |
11/05/2021
|
| | | | |
| 4.1 | | | | |
S-1/A
|
| |
333-204622
|
| |
4.1
|
| |
06/22/2015
|
| | | | |
| 5.1 | | | | | | | | | | | | | | | | |
X
|
| |
| 23.1 | | | | | | | | | | | | | | | | |
X
|
| |
| 23.2 | | | Consent of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP (contained in Exhibit 5.1) | | | | | | | | | | | | | | |
X
|
|
| 24.1 | | | Power of Attorney (contained in the signature page hereto) | | | | | | | | | | | | | | |
X
|
|
| 107 | | | | | | | | | | | | | | | | |
X
|
| |
Chief Financial Officer
| |
Signature
|
| |
Title
|
| |
Date
|
|
| |
/s/ STEVEN CHAPMAN
Steven Chapman
|
| |
Chief Executive Officer, President and Director (Principal Executive Officer)
|
| |
November 15, 2022
|
|
| |
/s/ MICHAEL BROPHY
Michael Brophy
|
| |
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
|
| |
November 15, 2022
|
|
| |
/s/ MATTHEW RABINOWITZ
Matthew Rabinowitz
|
| |
Executive Chairman
|
| |
November 15, 2022
|
|
| |
/s/ ROY BAYNES
Roy Baynes
|
| |
Director
|
| |
November 15, 2022
|
|
| |
/s/ ROELOF F. BOTHA
Roelof F. Botha
|
| |
Director
|
| |
November 15, 2022
|
|
| |
/s/ ROWAN E. CHAPMAN
Rowan E. Chapman
|
| |
Director
|
| |
November 15, 2022
|
|
| |
Signature
|
| |
Title
|
| |
Date
|
|
| |
/s/ JAMES I. HEALY
James I. Healy
|
| |
Director
|
| |
November 15, 2022
|
|
| |
/s/ GAIL MARCUS
Gail Marcus
|
| |
Director
|
| |
November 15, 2022
|
|
| |
/s/ HERM ROSENMAN
Herm Rosenman
|
| |
Director
|
| |
November 15, 2022
|
|
| |
/s/ JONATHAN SHEENA
Jonathan Sheena
|
| |
Director
|
| |
November 15, 2022
|
|
Exhibit 5.1
|
![]() |
November 15, 2022
Natera, Inc.
13011 McCallen Pass
Building A Suite 100
Austin, Texas 78753
Ladies and Gentlemen:
You have requested our opinion with respect to certain matters in connection with the sale and issuance by Natera, Inc., a Delaware corporation (the “Company”), of up to an aggregate offering price of $350,000,000 of shares of the Company’s common stock, par value $0.0001 per share (the “Shares”) (including up to an aggregate offering price of $52,500,000 of shares that may be sold pursuant to the exercise of an option to purchase additional shares), pursuant to the Registration Statement on Form S-3 (the “Registration Statement”) filed with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”), on November 15, 2022, and the related prospectus dated November 15, 2022 included in the Registration Statement (the “Prospectus”).
In connection with this opinion, we have examined and relied upon the Registration Statement, the Prospectus, the Company’s Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, as currently in effect, and the originals or copies certified to our satisfaction of such other documents, records, certificates, memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below. With your consent, we have relied upon certificates and other assurances of officers of the Company as to factual matters without having independently verified such factual matters. We have assumed the genuineness and authenticity of all documents submitted to us as originals, and the conformity to originals of all documents submitted to us as copies thereof and the due execution and delivery of all documents where due execution and delivery are a prerequisite to the effectiveness thereof.
This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the Prospectus, other than as expressly stated herein with respect to the issue of the Shares. Our opinion is limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated. Our opinion herein is expressed solely with respect to the federal laws of the United States and the General Corporation Law of the State of Delaware (the “DGCL”). Our opinion is based on these laws as in effect on the date hereof, and we disclaim any obligation to advise you of facts, circumstances, events or developments which hereafter may be brought to our attention and which may alter, affect or modify the opinion expressed herein. We are not rendering any opinion as to compliance with any federal or state antifraud law, rule or regulation relating to securities, or to the sale or issuance thereof.
Subject to the foregoing and the other matters set forth herein, it is our opinion that the Shares to be issued and sold by the Company pursuant to the Registration Statement, when issued, sold and delivered in the manner and for the consideration stated in the Registration Statement and the Prospectus, and when duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers, the Shares will be validly issued, fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL.


We consent to the reference to our firm under the caption “Legal Matters” in the Prospectus included in the Registration Statement and to the filing of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.
Sincerely,
| /s/GUNDERSON DETTMER STOUGH
VILLENEUVE FRANKLIN & HACHIGIAN, LLP |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" in this Registration Statement (Form S-3) and related Prospectus of Natera, Inc. for the registration of Common Stock and to the incorporation by reference therein of our reports dated February 24, 2022, with respect to the consolidated financial statements of Natera, Inc., and the effectiveness of internal control over financial reporting of Natera, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
San Mateo, California
November 15, 2022
